Clearmind Medicine gets IRB nod from TASMC for phase 1/2a clinical trial to evaluate CMND-100 for treatment of alcohol ...
Clearmind Medicine Inc, a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated health problems, announced that it has received Institutional Review Board (IRB) approval …